IO Biotech Inc (NASDAQ: IOBT) on Friday, soared 9.55% from the previous trading day, before settling in for the closing price of $1.78. Within the past 52 weeks, IOBT’s price has moved between $0.66 and $2.79.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -27.25%. The company achieved an average annual earnings per share of 8.45%. With a float of $49.27 million, this company’s outstanding shares have now reached $65.88 million.
IO Biotech Inc (IOBT) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of IO Biotech Inc is 25.21%, while institutional ownership is 20.21%. The most recent insider transaction that took place on May 30 ’25, was worth 20,884. In this transaction Director of this company bought 15,000 shares at a rate of $1.39, taking the stock ownership to the 15,000 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Medical Officer bought 31,350 for $0.85, making the entire transaction worth $26,553. This insider now owns 31,350 shares in total.
IO Biotech Inc (IOBT) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.34 earnings per share (EPS) for the period topping the consensus outlook (set at -0.35) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.59% during the next five years compared to -27.25% drop over the previous five years of trading.
IO Biotech Inc (NASDAQ: IOBT) Trading Performance Indicators
IO Biotech Inc (IOBT) is currently performing well based on its current performance indicators. A quick ratio of 1.96 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.58, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -0.98 in one year’s time.
Technical Analysis of IO Biotech Inc (IOBT)
Looking closely at IO Biotech Inc (NASDAQ: IOBT), its last 5-days average volume was 1.4 million, which is a jump from its year-to-date volume of 1.25 million. As of the previous 9 days, the stock’s Stochastic %D was 71.76%.
During the past 100 days, IO Biotech Inc’s (IOBT) raw stochastic average was set at 56.70%, which indicates a significant increase from 33.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2103 in the past 14 days, which was higher than the 0.1647 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7654, while its 200-day Moving Average is $1.1875. However, in the short run, IO Biotech Inc’s stock first resistance to watch stands at $2.0367. Second resistance stands at $2.1233. The third major resistance level sits at $2.2467. If the price goes on to break the first support level at $1.8267, it is likely to go to the next support level at $1.7033. Should the price break the second support level, the third support level stands at $1.6167.
IO Biotech Inc (NASDAQ: IOBT) Key Stats
Market capitalization of the company is 128.47 million based on 65,880K outstanding shares. Right now, sales total 0 K and income totals -95,490 K. The company made 0 K in profit during its latest quarter, and -26,220 K in sales during its previous quarter.
